Treating vulvovaginal atrophy/genitourinary syndrome of menopause: How important is vaginal lubricant and moisturizer composition?

Climacteric

Volumn 19, Issue 2, 2016, Pages 151-161

  Edwards, D ^a   Panay, N ^b  

^a Claridges Barn   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

Cytotoxicity; genitourinary syndrome of menopause; lubricant; moisturizer; osmolality; vaginal dryness; vulvovaginal atrophy

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ESTROGEN; EXCIPIENT; GLYCOL; LUBRICATING AGENT; MICROBICIDE; PRESERVATIVE;

ATTITUDE TO HEALTH; CYTOTOXICITY; DRUG CONTRAINDICATION; DYSPAREUNIA; ESTROGEN THERAPY; FEMALE FERTILITY; FERTILITY; HUMAN; MENOPAUSE RELATED DISORDER; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; VAGINA ATROPHY; VAGINA PH; VAGINAL DRYNESS; VAGINAL LUBRICATION; VAGINAL SECRETION; ATROPHY; FEMALE; INTRAVAGINAL DRUG ADMINISTRATION; MENOPAUSE; PATHOLOGY; PROCEDURES; QUALITY OF LIFE; VAGINA; VAGINAL DISEASES; VULVA; WOMEN'S HEALTH;

ADMINISTRATION, INTRAVAGINAL; ATROPHY; DYSPAREUNIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LUBRICANTS; MENOPAUSE; QUALITY OF LIFE; VAGINA; VAGINAL DISEASES; VULVA; WOMEN'S HEALTH;

EID: 84959346253     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2015.1124259     Document Type: Review

References (68)

1. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998; 15: 519-24
2. Leiblum SR, Hayes RD, Wanser RA, Nelson JS. Vaginal dryness: a comparison of prevalence and interventions in 11 countries. J Sex Med 2009; 6: 2425-33
3. Palacios S. Managing urogenital atrophy. Maturitas 2009; 63: 315-18
4. Panay N, Fenton A. Vulvovaginal atrophy-A tale of neglect. Climacteric 2014; 17: 1-2
5. Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 2014; 17: 557-63
6. Panay N. Genitourinary syndrome of the menopause-dawn of a new era. Climacteric 2015; 18 (Suppl 1): 13-17
7. Braunstein S, van de Wijgert J. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing. J Womens Health (Larchmt) 2005; 14: 424-33
8. Jozkowski KN, Herbenick D, Schick V, Reece M, Sanders SA, Fortenberry JD. Women's perceptions about lubricant use and vaginal wetness during sexual activities. J Sex Med 2013; 10: 484-92
9. Andelloux M. Products for sexual lubrication: understanding and addressing options with your patients. Nurs Womens Health 2011; 15: 253-7
10. Cordeau D, Courtois F. Sexual disorders in women with MS: assessment and management. Ann Phys Rehabil Med 2014; 57: 337-47
11. Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009; 29: 157-64
12. Sutton KS, Boyer SC, Goldfinger C, Ezer P, Pukall CF. To lube or not to lube: experiences and perceptions of lubricant use in women with and without dyspareunia. J Sex Med 2012; 9: 240-50
13. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996; 87: 55-8
14. Seehusen DA, Baird DC, Bode DV. Dyspareunia in women. Am Fam Physician 2014; 90: 465-70
15. Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction: classification, evaluation and treatment options. Eur Urol 2000; 38: 20-9
16. Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin Obstet Gynecol 2015; 58: 476-91
17. Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 2013; 10: 1790-9
18. Goldstein AT, Burrows LJ. Sexual Pain Disorders in Women 2009 [7 July 2015]. Available from: http://www.issm.info/news/review-reports/sexual-pain-disorders-in-women/
19. Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010; 13: 509-22
20. The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013; 20: 888-902
21. Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med 2013; 10: 1575-84
22. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000; 61: 3090-6
23. Sinha A, Ewies AA. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric 2013; 16: 305-12
24. Lammerink EA, de Bock GH, Schroder CP, Mourits MJ. The management of menopausal symptoms in breast cancer survivors: case-based approach. Maturitas 2012; 73: 265-8
25. Derzko C, Elliott S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 2007; 14 (Suppl 1): S20-40
26. Pruthi S, Simon JA, Early AP. Current overview of the management of urogenital atrophy in women with breast cancer. Breast J 2011; 17: 403-8
27. Simon JA, Kokot-Kierepa M, Goldstein J, Nappi RE. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause 2013; 20: 1043-8
28. Barlow DH, Cardozo LD, Francis RM., et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997; 104: 87-91
29. Herbenick D, Reece M, Hensel D, Sanders S, Jozkowski K, Fortenberry JD. Association of lubricant use with women's sexual pleasure, sexual satisfaction, and genital symptoms: a prospective daily diary study. J Sex Med 2011; 8: 202-12
30. World Health Organization. Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FHI360 advisory note 2012 [7 July 2015]. Available from: http://apps.who.int/iris/bitstream/10665/76580/1/WHO-RHR-12.33-eng.pdf
31. Willhite LA, OConnell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001; 21: 464-80
32. Herbenick D, Reece M, Schick V, Sanders SA, Fortenberry JD. Women's use and perceptions of commercial lubricants: prevalence and characteristics in a nationally representative sample of American adults. J Sex Med 2014; 11: 642-52
33. Cribby S, Taylor M, Reid G. Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis 2008; 2008: 256490
34. Raz R. Urinary tract infection in postmenopausal women. Korean J Urol 2011; 52: 801-8
35. Adriaens E, Remon JP. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis 2008; 35: 512-16
36. Agarwal A, Deepinder F, Cocuzza M, Short RA, Evenson DP. Effect of vaginal lubricants on sperm motility and chromatin integrity: a prospective comparative study. Fertil Steril 2008; 89: 375-9
37. Dezzutti CS, Brown ER, Moncla B., et al. Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PLoS One 2012; 7: e48328
38. Fuchs EJ, Lee LA, Torbenson MS., et al. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis 2007; 195: 703-10
39. Cunha AR, Machado RM, Palmeira-de-Oliveira A, Martinez-de-Oliveira J, das Neves J, Palmeira-de-Oliveira R. Characterization of commercially available vaginal lubricants: a safety perspective. Pharmaceutics 2014; 6: 530-42
40. Bledzka D, Gromadzinska J, Wasowicz W. Parabens. From environmental studies to human health. Environ Int 2014; 67: 27-42
41. Karpuzoglu E, Holladay SD, Gogal RM Jr. Parabens: potential impact of low-affinity estrogen receptor binding chemicals on human health. J Toxicol Environ Health B Crit Rev 2013; 16: 321-35
42. Nohynek GJ, Borgert CJ, Dietrich D, Rozman KK. Endocrine disruption: fact or urban legend? Toxicol Lett 2013; 223: 295-305
43. Harvey PW, Everett DJ. Significance of the detection of esters of p-hydroxybenzoic acid (parabens) in human breast tumours. J Appl Toxicol 2004; 24: 1-4
44. Moench TR, Mumper RJ, Hoen TE, Sun M, Cone RA. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infect Dis 2010; 10: 331
45. Fashemi B, Delaney ML, Onderdonk AB, Fichorova RN. Effects of feminine hygiene products on the vaginal mucosal biome. Microb Ecol Health Dis 2013; 24 doi: 10.3402/mehd.v24i0.19703. eCollection 2013
46. Brotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 2010; 86: 297-302
47. Kabara JJ, Orth DS. Preservative-Free and Self-Preserving Cosmetics and Drugs. Principles and Practice. New York: Marcel Dekker, Inc., 1997
48. Dayal MB, Wheeler J, Williams CJ, Barnhart KT. Disruption of the upper female reproductive tract epithelium by nonoxynol-9. Contraception 2003; 68: 273-9
49. Phillips DM, Zacharopoulos VR. Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice. Contraception 1998; 57: 341-8
50. Phillips DM, Taylor CL, Zacharopoulos VR, Maguire RA. Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium. Contraception 2000; 62: 149-54
51. Cone RA, Hoen T, Wong X, Abusuwwa R, Anderson DJ, Moench TR. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis 2006; 6: 90
52. Dhondt MM, Adriaens E, Remon JP. The evaluation of the local tolerance of vaginal formulations, with or without nonoxynol-9, using the slug mucosal irritation test. Sex Transm Dis 2004; 31: 229-35
53. Phillips DM, Sudol KM, Taylor CL, Guichard L, Elsen R, Maguire RA. Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception 2004; 70: 107-10
54. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 2002; 29: 655-64
55. Begay O, Jean-Pierre N, Abraham CJ., et al. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum Retroviruses 2011; 27: 1019-24
56. Steiner AZ, Long DL, Tanner C, Herring AH. Effect of vaginal lubricants on natural fertility. Obstet Gynecol 2012; 120: 44-51
57. Anderson L, Lewis SE, McClure N. The effects of coital lubricants on sperm motility in vitro. Hum Reprod 1998; 13: 3351-6
58. Frishman GN, Luciano AA, Maier DB. Evaluation of Astroglide, a new vaginal lubricant: effects of length of exposure and concentration on sperm motility. Fertil Steril 1992; 58: 630-2
59. Kutteh WH, Chao CH, Ritter JO, Byrd W. Vaginal lubricants for the infertile couple: effect on sperm activity. Int J Fertil Menopausal Stud 1996; 41: 400-4
60. Sandhu RS, Wong TH, Kling CA, Chohan KR. In vitro effects of coital lubricants and synthetic and natural oils on sperm motility. Fertil Steril 2014; 101: 941-4
61. Mowat A, Newton C, Boothroyd C, Demmers K, Fleming S. The effects of vaginal lubricants on sperm function: an in vitro analysis. J Assist Reprod Genet 2014; 31: 333-9
62. Amelar RD, Dubin L, Schoenfeld C. Sperm motility. Fertil Steril 1980; 34: 197-215
63. World Health Organization. WHO laboratory manual for the examination and processing of human semen, 5th edition 2010 [7 July 2015]. Available from: http://whqlibdoc.who.int/publications/2010/9789241547789-eng.pdf
64. Peek JC, Matthews CD. The pH of cervical mucus, quality of semen, and outcome of the post-coital test. Clin Reprod Fertil 1986; 4: 217-25
65. Rossato M, Balercia G, Lucarelli G, Foresta C, Mantero F. Role of seminal osmolarity in the reduction of human sperm motility. Int J Androl 2002; 25: 230-5
66. Connor CJ, Eppsteiner EE. Vulvar contact dermatitis. Proc Obstet Gynecol 2014; 4: 1
67. Majerovich JA, Canty A, Miedema B. Chronic vulvar irritation: could toilet paper be the culprit? Can Fam Physician 2010; 56: 350-2
68. Wolf LK. Studies raise questions about safety of personal lubricants. Chem Eng News 2012; 90: 46-7